Centaurus Financial’s Bausch Health BHC Stock Holding History

Centaurus Financial’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-10,000	Closed	-$1K	–	757
2023 Q1	$1K	Buy	+10,000	New	+$80.3K	﹤0.01%	899

Other funds holding BHC

Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

GAM

Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Centaurus Financial's BHC Position: Q2 2022 in Review

Centaurus Financial sold out of Bausch Health (BHC) in Q2 2022, closing a stake of 12,050 shares — an estimated $275K sold.

Centaurus Financial first reported a position in BHC in Q2 2018 and held it in 5 quarters. The position peaked at $275K in Q1 2022. 327 funds tracked by Wall St. Rank hold BHC as of Q2 2022.

Centaurus Financial reported no remaining Bausch Health position as of Q2 2022 after selling out during the quarter.
Centaurus Financial sold 12,050 Bausch Health shares in Q2 2022, an estimated $275K.
Centaurus Financial first reported a position in Bausch Health in Q2 2018 and held it in 5 quarters.
Centaurus Financial's Bausch Health position peaked at $275K in Q1 2022.
327 funds tracked by Wall St. Rank held Bausch Health as of Q2 2022.

Based on Centaurus Financial's 13F filing for Q2 2022, filed 2 Aug 2022.